Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.

NCT04337840 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04337840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04337840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 5, 2020
Completion date
March 31, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

klebsiella pneumoniae sepsis